Abstract
Following minor surgery performed under topical application of oxybuprocaine (Dorsacaine, Novesin) two patients suffered from fibrinous iritis and moderate corneal swelling. We believe that this represents a toxic reaction caused by an inadvertent entry of this drug into the anterior chamber during the procedure.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- EMMERICH R., CARTER G. Z., BERENS C. An experimental clinical evaluation of dorsacaine hydrochloride (benoxinate novesine); report on the instillation of a 0.4-percent solution. Am J Ophthalmol. 1955 Dec;40(6):841–848. doi: 10.1016/0002-9394(55)91114-4. [DOI] [PubMed] [Google Scholar]
- SCHLEGEL H. E., Jr, SWAN K. C. Benoxinate (dorsacaine) for rapid corneal anesthesia. AMA Arch Ophthalmol. 1954 May;51(5):663–670. doi: 10.1001/archopht.1954.00920040673010. [DOI] [PubMed] [Google Scholar]
- SPENCER R. W., SCHEIE H. G., DRIPPS R. D. Anterior chamber injection in the rabbit as a method for determining irritancy of local anesthetics. J Pharmacol Exp Ther. 1955 Apr;113(4):421–430. [PubMed] [Google Scholar]